References
- Wallen EM, Pruthi RS, Joyce GF, Wise M. Urologic Diseases in America Project. Kidney cancer. J Urol 2007; 177: 2006–18, discussion 2018–9
- Ljungberg B, Alamdari FI, Holmberg G, Granfors T, Duchek M. Radical nephrectomy is still preferable in the treatment of localized renal cell carcinoma. A long-term follow-up study. Eur Urol 1998; 33: 79–85
- Delahunt B, Bethwaite PB, Nacey JN. Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype. Pathology 2007; 39: 459–65
- Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 2003; 97: 1663–71
- Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumour stage, size, grade and necrosis: the SSIGN score. J Urol 2002; 168: 2395–400
- Thompson RH, Leibovich BC, Lohse CM, Cheville JC, Zincke H, Blute ML, et al. Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score. J Urol 2007; 177: 477–80
- Leibovitch I, Lev R, Mor Y, Golomb J, Dotan ZA, Ramon J. Extensive necrosis in renal cell carcinoma specimens: potential clinical and prognostic implications. Isr Med Assoc J 2001; 3: 563–5
- Foria V, Surendra T, Poller DN. Prognostic relevance of extensive necrosis in renal cell carcinoma. J Clin Pathol 2005; 58: 39–43
- Sabo E, Boltenko A, Sova Y, Stein A, Kleinhaus S, Resnick MB. Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin Cancer Res 2001; 7: 533–7
- Sengupta S, Lohse CM, Leibovich BC, Frank I, Thompson RH, Webster WS, et al. Histologic coagulative tumour necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer 2005; 104: 511–20
- Tollefson MK, Thompson RH, Sheinin Y, Lohse CM, Cheville JC, Leibovich BC, et al. KI-67 and coagulative tumour necrosis are independent predictors of poor outcome for patients with clear cell carcinoma and not surrogates for each other. Cancer 2007; 110: 783–90
- Zubac DP, Bostad L, Gestblom C, Kihl B, Seidal T, Wentzel-Larsen T, et al. Renal cell carcinoma: a clinicopathological follow up study after radical nephrectomy. Scand J Urol Nephrol 2007; 41: 191–7
- Lee SE, Byun SS, Oh JK, Lee SC, Chang IH, Choe G, et al. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma. J Urol 2006; 176: 1332–7, discussion 1337–8
- Lam JS, Shvarts O, Said JW, Pantuck AJ, Seligson DB, Aldridge ME, et al. Clinicopathologic and molecular correlations of necrosis in the primary tumour of patients with renal cell carcinoma. Cancer 2005; 103: 2517–25
- Dudderidge TJ, Stoeber K, Loddo M, Atkinson G, Fanshawe T, Griffiths DF, et al. Mcm2, Geminin, and Ki-67 define proliferative state and are prognostic markers in renal cell carcinoma. Clin Cancer Res 2005; 11: 2510–7
- Uzzo RG, Kolenko V, Froelich CJ, Tannenbaum C, Molto L, Novick AC, et al. The T cell death knell: immune mediated tumour death in renal cell carcinoma. Clin Cancer Res 2001; 7: 3276–81
- Erdemir F, Kilciler M, Bedir S, Ozgok Y, Coban H, Erten K. Clinical significance of platelet count in patients with renal cell carcinoma. Urol Int 2007; 79: 111–6